Original article

Ahead-of-Print

Quality and stability studies of red blood cell concentrates from umbilical cord blood compared to their adult counterparts

Authors

Key words: Cord blood, red blood cells, preterm infants

Abstract

Background - Prematurity is a significant health issue due to its incidence and associated complications. Anemia is common in extremely preterm infants (EPI) and often requires transfusions. Red blood cells (RBC) from adult blood (AB) donors have been linked to oxygen-related complications in EPI, leading to the exploration of cord blood (CB) as an alternative source. However, standardization of CB-RBC manufacturing and comparison with AB-RBC characteristics are necessary before clinical studies can be conducted.

Materials and methods - This study investigated the quality and characteristics of leukoreduced, gamma-irradiated CB-RBC obtained using a commercial closed system from CB donations not meeting hematopoietic transplantation criteria. CB-RBC units were compared with AB-RBC units, both stored in saline-adenine-glucose-mannitol (SAGM). Various parameters, including hematological and biochemical characteristics, pH, 2,3-DPG levels, blood gases and potential toxicants, were evaluated during storage.

Results - CB-RBC units had acceptable initial quality parameters and a hematocrit (55±2%) comparable to AB-RBC. The main finding during storage was a faster rise in hemolysis compared to AB-RBC. Potassium (K+) significantly increased during storage in both sources. As expected, glucose levels decreased, and conversely, lactate levels increased, indicating similar patterns of anaerobic glycolysis during storage. pH decreased, affecting the oxygen dissociation curve due to reduced 2,3-DPG levels. After  irradiation at 14 days of storage, CB-RBC were less stable as hemolysis and K+ significantly increased compared to AB-RBC at 24 hours. Phthalate concentrations, indicative of plasticizers, increased during storage, but significantly less in CB compared to AB-RBC. Most metals measured were within acceptable ranges.

Discussion - The quality of CB-RBC during storage is primarily influenced by levels of hemolysis and extracellular K+ content. Based on the analyzed parameters, we suggest that the expiration date for CB-RBC stored with SAGM should be set at 14 days, with transfusion occurring within <24 hours after irradiation.

Downloads

Authors

Dinara Samarkanova - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

Margarita Codinach - Transfusion Medicine study group of Vall de Hebron Research Institute, Spain; Cell Laboratory, Blood and Tissue Bank, Barcelona, Spain

Gemma Aran - Cell Laboratory, Blood and Tissue Bank, Barcelona, Spain

Mar Guitart - Life and Health Science Faculty, Pompeu and Fabra University, Barcelona, Spain

Elena Valdivia - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

Lluis Martorell - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

Carmen Azqueta - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

Marta Rodriguez-Aliberas - Immunohematology Laboratory, Blood and Tissue Bank, Barcelona, Spain

Gloria Soria - Transfusion Medicine study group of Vall de Hebron Research Institute, Spain; Microbiology Laboratory, Blood and Tissue Bank, Barcelona, Spain

Nuria Martinez - Blood Bank, Blood and Tissue Bank, Barcelona, Spain

Eva Alonso - Blood Bank, Blood and Tissue Bank, Barcelona, Spain; Human Milk Bank, Blood and Tissue Bank, Barcelona, Spain

Elisenda Farssac - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

Alejandro Madrigal - Royal Free Hospital Trust, NHS, Cancer Institute UCL, London, United Kingdom; Instituto Tecnologico de Monterrey, Monterrey, Mexico

Paolo Rebulla - Department of Transfusion Medicine and Hematology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Sergio Querol - Cell and Advanced Therapy Service, Blood and Tissue Bank, Barcelona, Spain; Transfusion Medicine study group of Vall de Hebron Research Institute, Spain

  • Abstract viewed - 301 times
  • pdf downloaded - 178 times